Cicas IP v. Meta Dynamic & Med-Surgical Services: Dismissed Without Prejudice After 161 Days
Cicas IP, LLC asserted two CBYON System patents against medical technology defendants Meta Dynamic, Inc. and Med-Surgical Services, Inc. in the Eastern District of Texas. The parties jointly resolved the dispute and obtained a dismissal without prejudice — with a notable one-year tolling agreement preserving both sides’ claims — just 161 days after filing.
CBYON System patent dispute ends in tolled dismissal without prejudice
On August 13, 2024, Cicas IP, LLC filed a patent infringement action in the Eastern District of Texas (Case No. 2:24-cv-00665) against Meta Dynamic, Inc. and Med-Surgical Services, Inc. The complaint asserted two patents — US6511418B2 and US6850794B2 — both relating to the CBYON System, a surgical navigation and medical imaging platform. Cicas IP, a dedicated IP licensing entity, targeted two defendants operating in the medical device and surgical services space.
The case closed on January 21, 2025, via a joint motion to dismiss filed by all parties. The court granted the motion and dismissed all claims and causes of action without prejudice. Critically, the dismissal order incorporates a one-year tolling agreement: any refiling within one year of the dismissal entry is deemed filed as of August 13, 2024, preserving the original filing date for statute of limitations and damages purposes. Each party was ordered to bear its own costs and attorneys’ fees.
At 161 days, the case resolved well within what typical Eastern District of Texas patent litigation timelines would suggest for a case reaching trial. The tolling agreement is commercially significant — it suggests the parties reached a business resolution but preserved optionality for either side to refile. The public record does not disclose whether a licensing agreement or financial settlement was reached, nor does it indicate which party initiated the joint motion. The without-prejudice posture means Cicas IP retains the right to reassert these patents within the tolling window.
Filing to Dismissed without Prejudice in 161 days
161 days — faster than the median EDTX patent case, suggesting early resolution or settlement pressure
Dismissed without prejudice: what the tolling agreement means for both parties
Without prejudice dismissal preserves the right to refile
A dismissal without prejudice does not adjudicate the merits of any claim. Unlike a with-prejudice dismissal, which extinguishes the asserted claims permanently, this order leaves Cicas IP free to reassert US6511418B2 and US6850794B2 against these defendants. The embedded tolling clause reinforces this: any refiling within one year is backdated to August 13, 2024, neutralising statute of limitations concerns that would otherwise accrue during the dismissed period.
No merits adjudicationCicas IP retains full enforcement rights under a one-year window
Cicas IP exits this action with its patents intact and unlitigated on the merits. The tolling agreement is particularly favourable: it prevents the defendants from later arguing that damages or claims are time-barred based on events occurring during the pendency of this case. If a licensing arrangement was reached privately, the without-prejudice structure also allows Cicas IP to refile if payment obligations are not met — a common IP licensing enforcement tactic.
Patents preserved; refiling right intactDefendants face residual litigation risk through at least January 2026
For Meta Dynamic and Med-Surgical Services, the dismissal without prejudice provides no immunity from future suit. The tolling agreement cuts both ways: while it protects any counterclaims or defenses the defendants may have accrued, it equally preserves Cicas IP’s damages claims. Defendants cannot treat this as a final resolution unless a binding confidential agreement exists. The one-year refiling window — running to approximately January 2026 — means defendants should monitor the status of any licensing arrangement carefully.
No immunity; tolling window runs ~Jan 2026Tolling clauses in patent dismissals signal structured licensing negotiations
The inclusion of a mutual tolling agreement — covering both parties’ claims, counterclaims, and defenses — is consistent with a negotiated resolution still in progress, or a licensing deal with performance conditions. Medical device and surgical navigation companies operating in the CBYON System technology space should treat this case as a signal that these patents remain actively enforced. Other parties in the surgical navigation or image-guided surgery sector using related technology should assess their exposure before the refiling window closes.
Active enforcement signal for med-tech sectorFull party and counsel information
| Role | Name | Type | Detail |
|---|---|---|---|
| Plaintiff | Cicas IP, LLC | Company | IP licensing entity — holder of US6511418B2 and US6850794B2 (CBYON System patents)Search in Eureka ↗ |
| Defendant | Meta Dynamic, Inc. | Company | Meta Dynamic, Inc. and Med-Surgical Services, Inc. — medical device and surgical services companiesSearch in Eureka ↗ |
| Co-Defendant | Med-Surigcal Services, Inc. | Company | Search in Eureka ↗ |
| Plaintiff counsel | Christopher A. Honea | Attorney | Counsel for Cicas IP, LLCSearch in Eureka ↗ |
| Plaintiff law firm | Garteiser Honea PLLC | Law Firm | Representing Cicas IP, LLCSearch in Eureka ↗ |
| Defendant counsel | Joshua M. Masur | Attorney | Counsel for Meta Dynamic, Inc.Search in Eureka ↗ |
| Defendant law firm | Haley Guiliano, LLP | Law Firm | Representing Meta Dynamic, Inc.Search in Eureka ↗ |
| Presiding judge | Judge N/A | Judge | Texas Eastern District CourtSearch in Eureka ↗ |
Official order — verbatim text
The court’s order adopts the parties’ joint stipulation verbatim, granting the dismissal without prejudice and embedding the tolling agreement as an enforceable term of the order. The without-prejudice designation is legally significant: it means the court made no finding on infringement, validity, or claim construction. The tolling clause — deeming any refiling within one year as filed on August 13, 2024 — is an unusual provision that suggests the parties negotiated the order’s terms carefully, likely to preserve damages periods and avoid any accrual gap.
US6511418B2 & US6850794B2 — CBYON Surgical Navigation System Patents
US6511418B2 and US6850794B2 are both associated with the CBYON System — a surgical navigation platform designed to guide image-based medical procedures. These patents, filed under application numbers US09/822545 and US09/957477 respectively, sit within the technical domain of computer-assisted surgery, integrating real-time imaging data with navigational guidance to support precision interventions. The CBYON designation suggests a specific branded system covering both hardware and software components of intraoperative navigation.
For companies operating in surgical robotics, image-guided therapy, orthopedic navigation, or computer-assisted surgical planning, these patents represent a potential enforcement risk that this litigation has left unresolved on the merits. The fact that Cicas IP — a dedicated licensing entity — chose to assert both patents simultaneously against both a device distributor and a services provider suggests a broad enforcement theory covering the full commercial chain. Competitors and partners in this space should evaluate their product and service architectures against the claims of both patents before the tolling window expires.
Should your team run an FTO against US6511418B2 and US6850794B2?
Any R&D team or product manager working on surgical navigation systems, image-guided procedures, or related computer-assisted surgery technology should treat this case as a trigger for a freedom-to-operate review. These patents remain valid, unexpired if still in force, and unlitigated on the merits. Cicas IP has demonstrated willingness to assert them in the Eastern District of Texas — a venue known for patent-holder-friendly outcomes — and the tolling agreement signals continued enforcement intent.
PatSnap Eureka’s FTO Search Agent can map the claim language of US6511418B2 and US6850794B2 against your product architecture, identify relevant prior art that could support invalidity arguments, and flag whether your technology falls within the likely claim scope. Given the without-prejudice dismissal and active tolling window, an FTO analysis completed now could inform both product design decisions and negotiation positioning if Cicas IP refiles or issues new demand letters.
Run a freedom-to-operate analysis on US6511418B2 to assess your product’s exposure
Run FTO in Eureka →Similar surgical navigation and medical device patent cases in EDTX
Explore comparable patent infringement actions in surgical navigation and computer-assisted surgery technology filed in the Eastern District of Texas, including cases involving IP licensing entities asserting medical device patents.
Related patent case — similar technology
Comparable case in the same technology domain. Patent holder and defendant reached resolution after proceedings.
SettledRelated infringement action — same court
Comparable CBYON System-adjacent infringement action. Patent enforcement dynamics analysed in depth.
Active · District CourtRelated invalidity challenge — appellate outcome
Combined invalidity and infringement action in the same technology space. Decided after substantive proceedings.
DecidedCicas IP, LLC’s broader IP enforcement history
Cicas IP, LLC’s full litigation history covering prior enforcement, licensing activity, and inter partes review proceedings.
Portfolio viewWhat this case signals for the surgical navigation IP landscape
A tolled dismissal without prejudice in the Eastern District of Texas rarely signals the end of enforcement — it typically signals a pause.
Tolling agreements signal conditional resolution, not finality
When a joint dismissal incorporates a one-year tolling clause, it suggests the parties reached an arrangement with performance conditions or are still negotiating final terms. IP professionals monitoring CBYON System-related patents should treat this as an open enforcement posture, not a resolved dispute. The patents remain unchallengeable on their merits based on this case record.
Eastern District of Texas remains a high-pressure venue for early resolution
At 161 days, this case resolved far faster than the typical EDTX patent case reaching claim construction. The venue’s reputation for plaintiff-friendly scheduling and rapid discovery timelines consistently incentivises defendants to negotiate early. Companies receiving demand letters tied to EDTX filings should factor in this settlement pressure dynamic when assessing litigation risk.
US6511418B2 and US6850794B2 enforcement posture: what prior art searches reveal
With both CBYON System patents surviving this case unexamined on the merits, any company in the surgical navigation or image-guided procedure space faces unresolved infringement risk. A targeted prior art search and claim mapping exercise against US6511418B2 and US6850794B2 is now commercially urgent for competitors.
Med-tech licensing exposure: which product categories are most at risk
The involvement of both a device company (Meta Dynamic) and a services company (Med-Surgical Services) suggests Cicas IP’s enforcement theory extends beyond hardware to service delivery models incorporating CBYON-type navigation systems. Companies in surgical planning software, image-guided robotics, or similar services should assess claim scope carefully.
Cicas v Meta — key questions answered
The dismissal without prejudice means no merits determination was made. Cicas IP retains the right to refile suit asserting US6511418B2 and US6850794B2 against the same defendants. The court-ordered tolling agreement further protects Cicas IP by deeming any refiling within one year of dismissal as having been filed on August 13, 2024, preserving the original filing date for damages and statute of limitations purposes.
The CBYON System is a surgical navigation and image-guided medical procedure platform. In this case, Cicas IP asserted two patents covering the system: US6511418B2 (application US09/822545) and US6850794B2 (application US09/957477). Both relate to computer-assisted surgery technology integrating imaging data with intraoperative navigation guidance.
The tolling agreement is a mutual stipulation that pauses all time limitations and time bars — including damages accrual periods — during the pendency of this case. It means neither party can use the passage of time during this litigation as a defense in a future refiling. This is commercially significant because it keeps the defendants’ exposure fully intact for approximately one year post-dismissal, consistent with a conditional or structured settlement arrangement.
The Eastern District of Texas is a historically favoured venue for patent assertion entities due to its patent-holder-friendly procedures, experienced patent docket, and scheduling orders that create early settlement pressure on defendants. Cicas IP is represented by Garteiser Honea PLLC, a firm with extensive EDTX patent litigation experience, which is consistent with a strategic choice of venue by the plaintiff.
The court ordered each party to bear its own costs, expenses, and attorneys’ fees. No fee-shifting was imposed under 35 U.S.C. § 285 or Rule 54. This is a standard term in jointly stipulated dismissals and does not reflect any finding that either party’s conduct was exceptional or warranted sanctions.
Don’t wait for the refiling — assess your surgical navigation IP exposure now
With the CBYON System patents unlitigated on the merits and a one-year tolling window in effect, companies in surgical navigation and image-guided surgery face unresolved risk. PatSnap Eureka’s FTO and monitoring tools help you stay ahead of Cicas IP’s next move.
PatSnap Eureka searches patents and litigation data to answer instantly.